US Markets
PFE

Pfizer says could apply for U.S. emergency use approval for vaccine in late November

Credit: REUTERS/Carlo Allegri

Pfizer Inc said on Friday it would apply for emergency use in the United States of its COVID-19 vaccine candidate being developed along with Germany's BioNTech SE as soon as a safety milestone is achieved in the third week of November.

Oct 16 (Reuters) - Pfizer Inc PFE.N said on Friday it would apply for emergency use in the United States of its COVID-19 vaccine candidate being developed along with Germany's BioNTech SE 22UAy.F as soon as a safety milestone is achieved in the third week of November.

(Reporting by Manojna Maddipatla in Bengaluru Editing by Saumyadeb Chakrabarty)

((manojna.kalyani@thomsonreuters.com; +91 8061822700;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

PFE

Latest Markets Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More